エピソード

  • Pharmacological and Combination Interventions for Nicotine Cessation
    2026/06/30

    Master the latest evidence-based meds and dual therapies to help your patients quit for good.

    Credit available for this activity expires: 06/25/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.staging.medscape.org/viewarticle/pharmacological-and-combination-interventions-nicotine-2026a1000ldi?ecd=bdc_podcast_libsyn_mscpedu

    続きを読む 一部表示
    33 分
  • Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?
    2026/06/26

    Is sustained hemostatic normalization achievable across all hemophilia A patients? Examine the evidence behind today's therapeutic advances.

    Credit available for this activity expires: 6/26/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/normalizing-hemostasis-achievable-goal-hemophilia-2026a1000jxv?ecd=bdc_podcast_libsyn_mscpedu

    続きを読む 一部表示
    30 分
  • The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management
    2026/06/26

    Drs García-Pavia and Sperry break down the top 5 mistakes in transthyretin amyloid cardiomyopathy (ATTR-CM) management and share clinical solutions for earlier, optimized patient care.

    Credit available for this activity expires: 6/25/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/top-5-errors-transthyretin-amyloid-cardiomyopathy-management-2026a1000jpe?ecd=bdc_podcast_libsyn_mscpedu

    続きを読む 一部表示
    18 分
  • Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice
    2026/06/23

    Learn to optimize durability and drying with new second-generation anti-VEGF therapies.

    Credit available for this activity expires: 6/19/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/https://www.medscape.org/viewarticle/better-drying-longer-lasting-second-generation-anti-vegf-2026a1000k53?ecd=bdc_podcast_libsyn_mscpedu

    続きを読む 一部表示
    37 分
  • Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies
    2026/06/17

    Do you know how tumor-agnostic therapies are helping to reshape cancer treatment pathways?

    Credit available for this activity expires: 6/16/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/shaping-future-precision-oncology-biomarker-driven-care-2026a1000jpk?ecd=bdc_podcast_libsyn_mscpedu

    続きを読む 一部表示
    23 分
  • Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors
    2026/06/17

    Which patients with Alagille syndrome benefit from IBAT inhibitors, and what should you watch for during therapy?

    Credit available for this activity expires: 6/16/27
    Earn Credit / Learning Objectives & Disclosures:
    https://www.medscape.org/viewarticle/navigating-management-alagille-syndrome-using-ileal-bile-2026a1000g3c?ecd=bdc_podcast_libsyn_mscpedu

    続きを読む 一部表示
    22 分
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes
    2026/06/05

    How does it feel to live with CIDP? Bridge the gap between metrics and patient reality. Align goals and improve outcomes via shared decision-making.

    Credit available for this activity expires: 6/4/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-inflammatory-demyelinating-polyradiculoneuropathy-2026a1000g2n?ecd=bdc_podcast_libsyn_mscpedu

    続きを読む 一部表示
    26 分
  • The Molecular Nuances of Hemostasis: Differentiating FVIII and Non-Factor Replacement
    2026/06/02

    Do you know how the different therapies act in hemophilia A?

    Credit available for this activity expires: 05/29/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/molecular-nuances-hemostasis-differentiating-fviii-and-non-2026a1000hk2?ecd=bdc_podcast_libsyn_mscpedu

    続きを読む 一部表示
    29 分